Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2003
07/29/2003CA2097931C Salmonella vaccines
07/29/2003CA2069724C Process for making peptides containing aza-amino acids
07/29/2003CA2069481C Purified igc immunoglobulins
07/29/2003CA2067136C Growth hormone antagonists
07/29/2003CA2017157C Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
07/29/2003CA2012125C Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy
07/29/2003CA1341435C Recombinant pox virus for immunization against tumor-associated antigens
07/25/2003WO2002057787A2 Detection of survivin in the biological fluids of cancer patients
07/25/2003CA2437305A1 Detection of survivin in urine of bladder cancer patients
07/25/2003CA2425623A1 Promoter promoting expression of a foreign gene in root and shoot apex
07/24/2003WO2003060525A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases
07/24/2003WO2003060516A1 Screening method
07/24/2003WO2003060473A2 Mucin immobilized chromatography
07/24/2003WO2003060465A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
07/24/2003WO2003060151A2 Novel calpastatin (cast) alleles
07/24/2003WO2003060150A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
07/24/2003WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003WO2003060148A2 Androgen regulated nucleic acid molecules and encoded proteins
07/24/2003WO2003060146A2 Compositions and methods relating to urinary specific genes and proteins
07/24/2003WO2003060145A2 Compositions and methods relating to pancreatic specific genes and proteins
07/24/2003WO2003060143A2 Efficient protein expression system
07/24/2003WO2003060141A1 Manufacturing method of recombinant protein in yeast by the use of secretory type vector
07/24/2003WO2003060135A2 Use of a wdv promoter for phloem-specific expression
07/24/2003WO2003060131A1 SUGAR TRANSFERASE GnT-V HAVING ANGIOGENIC EFFECT
07/24/2003WO2003060128A2 Compositions, methods and systems for discovery of lipopeptides
07/24/2003WO2003060127A2 Genes and proteins involved in the biosynthesis of lipopeptides
07/24/2003WO2003060126A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis
07/24/2003WO2003060125A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE
07/24/2003WO2003060124A1 NOVEL PROTEINS PARTICIPATING IN STRESS RESPONSE VIA THE ACTIVATION OF p38 MAPK AND GENES THEREOF
07/24/2003WO2003060123A1 Compositions and methods for identifying transformed cells
07/24/2003WO2003060122A1 Compositions and methods relating to urinary specific genes and proteins
07/24/2003WO2003060121A2 Compositions and methods relating to gastric specific genes and proteins
07/24/2003WO2003060120A2 Means for identifying neisseiria menengitidis specific genes
07/24/2003WO2003060118A1 Iron-sulfur protein, protein-fad complex, electron transporter and method of measuring the inhibition of ferredotoxin activity
07/24/2003WO2003060105A1 Defective entities and uses therefor
07/24/2003WO2003060103A2 Minimal dna binding domain polynucleotides, polypeptides, and uses thereof
07/24/2003WO2003060099A2 Methods and apparatus for spinning spider silk protein
07/24/2003WO2003060098A2 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna
07/24/2003WO2003060096A2 Assay for the detection of factors that modulate the expression of ingap
07/24/2003WO2003060093A2 METHODS AND COMPOSITIONS FOR PROPAGATING VECTORS CONTAINING TOXIC cDNAs AND ION CHANNEL ASSAY SYSTEMS
07/24/2003WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists
07/24/2003WO2003060090A2 Novel cytokine zcytor17 ligand
07/24/2003WO2003060089A2 Metalloproteins
07/24/2003WO2003060088A2 Viral vaccine production method
07/24/2003WO2003060086A2 Napi type iib polypeptides and methods for making and using same
07/24/2003WO2003060074A2 Novel metastasis suppressor gene on human chromosome 8
07/24/2003WO2003060072A2 Recombinant polypeptides
07/24/2003WO2003060071A2 Albumin fusion proteins
07/24/2003WO2003060069A2 Compositions and methods relating to hepatic specific genes and proteins
07/24/2003WO2003060068A2 Oxa1p enhanced protein secretion
07/24/2003WO2003060067A2 P85-alpha nucleic acids, polypeptides and related methods
07/24/2003WO2003060066A2 Nucleic acid delivery and expression
07/24/2003WO2003060065A2 Adapter-directed display system
07/24/2003WO2003060064A2 Intracellular signaling molecules
07/24/2003WO2003059954A2 Method for specifically immobilizing mediator molecules on substrate surfaces
07/24/2003WO2003059950A1 Ifnar2 mutants, their production and use
07/24/2003WO2003059949A2 A protein that mediates angiogenesis and tumour growth inhibition, its cdna, alone or in complex with an expression vector
07/24/2003WO2003059948A1 Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
07/24/2003WO2003059947A1 Regulation of human neurotransmitter transporter
07/24/2003WO2003059946A2 Genetic polymorphisms predicting cardiovascular disease and medication efficacy
07/24/2003WO2003059945A2 Soluble recombinant protein production
07/24/2003WO2003059944A2 Gb virus b based replicons and replicon enhanced cells
07/24/2003WO2003059941A1 Biomolecule transduction motif mph-1-btm and the use thereof
07/24/2003WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof
07/24/2003WO2003059938A1 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
07/24/2003WO2003059936A2 Phytophthora Infestans CDC 14 Phosphatase Gene, Protein and Methods of Use
07/24/2003WO2003059935A2 Methods for purifying protein
07/24/2003WO2003059934A2 Albumin fusion proteins
07/24/2003WO2003059932A2 Methods of inducing or enhancing connective tissue repair
07/24/2003WO2003059928A1 Polynucleotide encoding an ap-2 domain transcription factor
07/24/2003WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins
07/24/2003WO2003059846A1 Highly homogenous serum albumin as chiral selector
07/24/2003WO2003059436A2 Compositions and methods for promoting myocardial and peripheral angiogenesis
07/24/2003WO2003059407A1 Surface-modified implants
07/24/2003WO2003059397A2 Labeling targeting agents with gallium-68 and gallium-67
07/24/2003WO2003059396A1 Adiponectin gene therapy
07/24/2003WO2003059395A2 Antisense compounds directed against human csf-1
07/24/2003WO2003059386A2 Prion protein carrier-conjugates
07/24/2003WO2003059385A2 Hiv vaccine and method of use
07/24/2003WO2003059384A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus
07/24/2003WO2003059381A2 Immunogenic preparations and vaccines on the basis of mrna
07/24/2003WO2003059379A2 Immunogenic carcinoembryonic antigen (cea)
07/24/2003WO2003059378A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia
07/24/2003WO2003059374A2 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain
07/24/2003WO2003059290A2 Diagnostic and therapeutic uses of topors
07/24/2003WO2003059281A2 Novel variants of rankl protein
07/24/2003WO2003059268A2 A novel germ cell-specific contraceptive target
07/24/2003WO2003059262A2 Method and composition for treating and preventing hiv infection and aids
07/24/2003WO2003059257A2 Anti-angiogenic proteins and fragmentsand methods of use thereof
07/24/2003WO2003059252A2 Use of a novel cell surface protease from group b streptococcus
07/24/2003WO2003059248A2 Pigment epithelium derived factor from human plasma and methods of use thereof
07/24/2003WO2003059054A1 Transgenic mouse with disrupted calcium ion channel alpha1b gene and production method thereof
07/24/2003WO2003059053A2 Rabbit nuclear cloning method and uses thereof
07/24/2003WO2003046200A3 Methods for ligand discovery
07/24/2003WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same
07/24/2003WO2003029291A3 Pegylated and diglycosylated erythropoietin
07/24/2003WO2003027140A3 Identification of s. typhimurium genes by software-based genome comparison
07/24/2003WO2003022989A3 Therapeutic agents that inhibit the tup1 pathway
07/24/2003WO2003022884A3 Methods for construction and screening of libraries of chemokine variants
07/24/2003WO2003020903A3 Dna binding protein
1 ... 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 ... 2916